Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1681
    +0.0024 (+0.21%)
     
  • GBP/USD

    1.2497
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    51,179.07
    -601.26 (-1.16%)
     
  • CMC Crypto 200

    1,332.83
    -63.70 (-4.56%)
     
  • S&P 500

    5,105.93
    +57.51 (+1.14%)
     
  • DOW

    38,284.73
    +198.93 (+0.52%)
     
  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     
  • GOLD FUTURES

    2,350.50
    +8.00 (+0.34%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Gilead Sciences’ Cash Flows, Valuations, and Price Performance

Gilead Sciences’ Cash Flows, Valuations, and Price Performance

Gilead Sciences (GILD) stock has corrected 9.6% since the start of 2018 to close at $66.99 on May 15. In comparison, Johnson & Johnson (JNJ), Pfizer (PFE), and Merck & Co. (MRK) have returned -9.5%, -2.1%, and 5.3%, respectively.